世卫组织认可新的减肥药物 GLP-1 激动剂，而科学家们则致力于研究一种更安全的四激动剂药物。 WHO endorses new weight-loss drugs, GLP-1 agonists, while scientists work on a safer tetra-agonist drug.

世界卫生组织(世卫组织)建议使用叫做GLP-1的减重新药物治疗肥胖症和2型糖尿病,敦促采用更廉价的通用药物,使全世界更容易获得。 The World Health Organization (WHO) recommends new weight-loss drugs called GLP-1 agonists for treating obesity and type 2 diabetes, urging for cheaper generic versions to make them more accessible worldwide. 与此同时,科学家们正在研制一种针对四种荷尔蒙的新的四刺激药物,目的是有效减肥,减少副作用。 Meanwhile, scientists are developing a new tetra-agonist drug targeting four hormones, aiming for effective weight loss with fewer side effects. 但是,人们对使用GLP-1药物的年轻妇女的潜在风险提出了关切,要求进一步研究。 However, concerns about potential risks for young women using GLP-1 drugs have been raised, calling for further research.